Literature DB >> 2410505

Carbohydrate determinants associated with carcinoembryonic antigen (CEA).

E J Nichols, R Kannagi, S I Hakomori, M J Krantz, A Fuks.   

Abstract

The reactivities of eight purified preparations of carcinoembryonic antigen with monoclonal antibodies directed to tumor-associated carbohydrate determinants have been studied. All eight preparations showed strong reactivities with AH6, which defines Y structure (Fuc alpha 1----2Gal beta 1----4[Fuc alpha 1----3] GlcNAc beta 1----R), whereas only a few preparations showed reactivity with FH4-defining dimeric X determinants, (Gal beta 1----4 [Fuc alpha 1----3]GlcNAc beta 1----3Gal beta 1----4 [Fuc alpha 1----3]GlcNA beta 1----3Gal beta 1----R). No other antibodies tested showed any reactivity with these preparations. These carbohydrate markers associated with carcinoembryonic antigen will be useful to enhance the diagnostic value of the antigen.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2410505

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  A chemical reporter strategy to probe glycoprotein fucosylation.

Authors:  David Rabuka; Sarah C Hubbard; Scott T Laughlin; Sulabha P Argade; Carolyn R Bertozzi
Journal:  J Am Chem Soc       Date:  2006-09-20       Impact factor: 15.419

2.  Co-expression of X-hapten-like antigen and antigen YH206 on mucin molecules.

Authors:  Y Hinoda; K Imai; T Ban; F Itoh; A Yachi
Journal:  Gastroenterol Jpn       Date:  1991-02

3.  Plant-derived anti-Lewis Y mAb exhibits biological activities for efficient immunotherapy against human cancer cells.

Authors:  Robert Brodzik; Magdalena Glogowska; Katarzyna Bandurska; Monika Okulicz; Deepali Deka; Kisung Ko; Joke van der Linden; Jeanette H W Leusen; Natalia Pogrebnyak; Maxim Golovkin; Zenon Steplewski; Hilary Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-23       Impact factor: 11.205

4.  Quantitative considerations supporting the irrelevance of circulating serum CEA for the immunoscintigraphic visualization of CEA expressing carcinomas.

Authors:  K Bosslet; A Steinsträsser; A Schwarz; H P Harthus; G Lüben; L Kuhlmann; H H Sedlacek
Journal:  Eur J Nucl Med       Date:  1988

5.  Heterogeneous expression of two oncodevelopmental antigens, CEA and SSEA-1, in colorectal cancer.

Authors:  S H Itzkowitz; Z R Shi; Y S Kim
Journal:  Histochem J       Date:  1986-04

6.  Breast cancer humoral immune response: involvement of Lewis y through the detection of circulating immune complexes and association with Mucin 1 (MUC1).

Authors:  Marina Isla Larrain; Sandra Demichelis; Marina Crespo; Ezequiel Lacunza; Alberto Barbera; Aldo Cretón; Francisco Terrier; Amada Segal-Eiras; María Virginia Croce
Journal:  J Exp Clin Cancer Res       Date:  2009-08-28

Review 7.  Production of monoclonal antibodies in plants for cancer immunotherapy.

Authors:  Ghislain Moussavou; Kisung Ko; Jeong-Hwan Lee; Young-Kug Choo
Journal:  Biomed Res Int       Date:  2015-10-15       Impact factor: 3.411

8.  Fucosylated Glycans in α1-Acid Glycoprotein for Monitoring Treatment Outcomes and Prognosis of Cancer Patients.

Authors:  Shin Yazawa; Ryo Takahashi; Takehiko Yokobori; Rie Sano; Akira Mogi; Abby R Saniabadi; Hiroyuki Kuwano; Takayuki Asao
Journal:  PLoS One       Date:  2016-06-13       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.